Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Clinical trial NCT00146614 · COMPLETED

Trial details

NCT number: NCT00146614
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Hematologic Malignancies

Start date: 2002-07-01
Primary completion: 2003-04-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.